Quality assurance and risk reduction guidelines

D. R. Mody, D. D. Davey, M. Branca, S. S. Raab, U. G. Schenck, M. W. Stanley, R. G. Wright, M. Arbyn, D. Beccati, John W Bishop, L. Martins Collaco, S. F. Cramer, P. Fitzgerald, J. Heinrich, N. C. Jhala, G. Montanari, K. Kapila, S. Naryshkin, H. Z. Suprun

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Cervical cancer continues to be a major cause of death in women worldwide. The major problem facing most women is the unavailability of screening Pap tests in poor and underdeveloped countries. While rates of cancer deaths have decreased 60-80% in developed countries since the Pap test became available, the accuracy of Paps was challenged recently. In order to instill public confidence and promote optimal patient care, measures to improve the quality of the entire screening process should be undertaken. Continuous quality improvement processes are more appropriate than traditional quality assurance monitors. Although no standards can be defined that are applicable to all laboratory settings and nations, this document provides current views on universal quality procedures and risk reduction. Procedure/policy manuals, workload assessment, hierarchic/peer review, discrepancy analysis, rescreening studies and cytohistologic correlation are examples of universally applicable quality tools. The variability in practices in different parts of the world is also discussed.

Original languageEnglish (US)
Pages (from-to)496-507
Number of pages12
JournalActa Cytologica
Volume44
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

Papanicolaou Test
Risk Reduction Behavior
Guidelines
Peer Review
Quality Improvement
Workload
Developed Countries
Uterine Cervical Neoplasms
Cause of Death
Patient Care
Mortality
Neoplasms

Keywords

  • Cervix neoplasms
  • Mass screening
  • Papanicolaou smear

ASJC Scopus subject areas

  • Anatomy
  • Cell Biology
  • Histology

Cite this

Mody, D. R., Davey, D. D., Branca, M., Raab, S. S., Schenck, U. G., Stanley, M. W., ... Suprun, H. Z. (2000). Quality assurance and risk reduction guidelines. Acta Cytologica, 44(4), 496-507.

Quality assurance and risk reduction guidelines. / Mody, D. R.; Davey, D. D.; Branca, M.; Raab, S. S.; Schenck, U. G.; Stanley, M. W.; Wright, R. G.; Arbyn, M.; Beccati, D.; Bishop, John W; Martins Collaco, L.; Cramer, S. F.; Fitzgerald, P.; Heinrich, J.; Jhala, N. C.; Montanari, G.; Kapila, K.; Naryshkin, S.; Suprun, H. Z.

In: Acta Cytologica, Vol. 44, No. 4, 2000, p. 496-507.

Research output: Contribution to journalArticle

Mody, DR, Davey, DD, Branca, M, Raab, SS, Schenck, UG, Stanley, MW, Wright, RG, Arbyn, M, Beccati, D, Bishop, JW, Martins Collaco, L, Cramer, SF, Fitzgerald, P, Heinrich, J, Jhala, NC, Montanari, G, Kapila, K, Naryshkin, S & Suprun, HZ 2000, 'Quality assurance and risk reduction guidelines', Acta Cytologica, vol. 44, no. 4, pp. 496-507.
Mody DR, Davey DD, Branca M, Raab SS, Schenck UG, Stanley MW et al. Quality assurance and risk reduction guidelines. Acta Cytologica. 2000;44(4):496-507.
Mody, D. R. ; Davey, D. D. ; Branca, M. ; Raab, S. S. ; Schenck, U. G. ; Stanley, M. W. ; Wright, R. G. ; Arbyn, M. ; Beccati, D. ; Bishop, John W ; Martins Collaco, L. ; Cramer, S. F. ; Fitzgerald, P. ; Heinrich, J. ; Jhala, N. C. ; Montanari, G. ; Kapila, K. ; Naryshkin, S. ; Suprun, H. Z. / Quality assurance and risk reduction guidelines. In: Acta Cytologica. 2000 ; Vol. 44, No. 4. pp. 496-507.
@article{23b7574c1df94e3092dc20371afcedf1,
title = "Quality assurance and risk reduction guidelines",
abstract = "Cervical cancer continues to be a major cause of death in women worldwide. The major problem facing most women is the unavailability of screening Pap tests in poor and underdeveloped countries. While rates of cancer deaths have decreased 60-80{\%} in developed countries since the Pap test became available, the accuracy of Paps was challenged recently. In order to instill public confidence and promote optimal patient care, measures to improve the quality of the entire screening process should be undertaken. Continuous quality improvement processes are more appropriate than traditional quality assurance monitors. Although no standards can be defined that are applicable to all laboratory settings and nations, this document provides current views on universal quality procedures and risk reduction. Procedure/policy manuals, workload assessment, hierarchic/peer review, discrepancy analysis, rescreening studies and cytohistologic correlation are examples of universally applicable quality tools. The variability in practices in different parts of the world is also discussed.",
keywords = "Cervix neoplasms, Mass screening, Papanicolaou smear",
author = "Mody, {D. R.} and Davey, {D. D.} and M. Branca and Raab, {S. S.} and Schenck, {U. G.} and Stanley, {M. W.} and Wright, {R. G.} and M. Arbyn and D. Beccati and Bishop, {John W} and {Martins Collaco}, L. and Cramer, {S. F.} and P. Fitzgerald and J. Heinrich and Jhala, {N. C.} and G. Montanari and K. Kapila and S. Naryshkin and Suprun, {H. Z.}",
year = "2000",
language = "English (US)",
volume = "44",
pages = "496--507",
journal = "Acta Cytologica",
issn = "0001-5547",
publisher = "Science Printers and Publishers Inc.",
number = "4",

}

TY - JOUR

T1 - Quality assurance and risk reduction guidelines

AU - Mody, D. R.

AU - Davey, D. D.

AU - Branca, M.

AU - Raab, S. S.

AU - Schenck, U. G.

AU - Stanley, M. W.

AU - Wright, R. G.

AU - Arbyn, M.

AU - Beccati, D.

AU - Bishop, John W

AU - Martins Collaco, L.

AU - Cramer, S. F.

AU - Fitzgerald, P.

AU - Heinrich, J.

AU - Jhala, N. C.

AU - Montanari, G.

AU - Kapila, K.

AU - Naryshkin, S.

AU - Suprun, H. Z.

PY - 2000

Y1 - 2000

N2 - Cervical cancer continues to be a major cause of death in women worldwide. The major problem facing most women is the unavailability of screening Pap tests in poor and underdeveloped countries. While rates of cancer deaths have decreased 60-80% in developed countries since the Pap test became available, the accuracy of Paps was challenged recently. In order to instill public confidence and promote optimal patient care, measures to improve the quality of the entire screening process should be undertaken. Continuous quality improvement processes are more appropriate than traditional quality assurance monitors. Although no standards can be defined that are applicable to all laboratory settings and nations, this document provides current views on universal quality procedures and risk reduction. Procedure/policy manuals, workload assessment, hierarchic/peer review, discrepancy analysis, rescreening studies and cytohistologic correlation are examples of universally applicable quality tools. The variability in practices in different parts of the world is also discussed.

AB - Cervical cancer continues to be a major cause of death in women worldwide. The major problem facing most women is the unavailability of screening Pap tests in poor and underdeveloped countries. While rates of cancer deaths have decreased 60-80% in developed countries since the Pap test became available, the accuracy of Paps was challenged recently. In order to instill public confidence and promote optimal patient care, measures to improve the quality of the entire screening process should be undertaken. Continuous quality improvement processes are more appropriate than traditional quality assurance monitors. Although no standards can be defined that are applicable to all laboratory settings and nations, this document provides current views on universal quality procedures and risk reduction. Procedure/policy manuals, workload assessment, hierarchic/peer review, discrepancy analysis, rescreening studies and cytohistologic correlation are examples of universally applicable quality tools. The variability in practices in different parts of the world is also discussed.

KW - Cervix neoplasms

KW - Mass screening

KW - Papanicolaou smear

UR - http://www.scopus.com/inward/record.url?scp=0033900080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033900080&partnerID=8YFLogxK

M3 - Article

C2 - 10934940

AN - SCOPUS:0033900080

VL - 44

SP - 496

EP - 507

JO - Acta Cytologica

JF - Acta Cytologica

SN - 0001-5547

IS - 4

ER -